Implementation Project Manager
Pubblicato il 15-10-2026 - Eurofins in Vimodrone
Eurofins Scientific is an international life sciences company offering a unique range of analytical services to customers in multiple industries, with the aim of making life and the environment safer, healthier, and more sustainable. From the food you eat and the water you drink to the medicines you trust, Eurofins laboratories work with the world's largest companies to ensure that the products they supply are safe, the ingredients are authentic, and the labeling is accurate.
Eurofins is committed to providing analytical services that contribute to the health and safety of society and the planet, as well as corporate responsibility to protect the environment and promote diversity, equity, and inclusion across the Eurofins network of companies.
The Eurofins network of companies believes it is a global leader in food, environmental, pharmaceutical, and cosmetic analysis, as well as in discovery pharmacology, forensic medicine, advanced materials science, and agro‑scientific research services. It is also a market leader in certain areas of genomics, clinical trial support,
and contract development and manufacturing in the biopharmaceutical field. It also has a rapidly expanding presence in the highly specialized field of molecular clinical diagnostics and in vitro diagnostic products.
In over 37 years, Eurofins has grown from a single laboratory in Nantes, France, with more than 65,000 employees in a decentralized and entrepreneurial network of over 950 laboratories in more than 1,000 companies across 59 countries. Eurofins companies offer a portfolio of over 200,000 analytical methods to assess the safety, identity, composition, authenticity, origin, traceability, and purity of biological substances and products.
In 2025, Eurofins generated total revenues of €7.296 billion and was among the best-performing stocks in Europe over the past 20 years.
Job Description
Eurofins Biopharma Product Testingis looking for aProject Manager, at EU level, who will be focused o